SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77763.91
261.79 (0.34%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Ipca Laboratories Ltd.	Q V+ PT	45,182 Mid Cap	1,780.90 (3.64%)	39.9	5.66	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Poly Medicure Ltd.	Q V PT	17,029 Small Cap	1,680.05 (-3.32%)	50.68	5.58	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Onesource Specialty Pharma Ltd.	Q V PT	19,131 Small Cap	1,668.70 (-1.11%)	901.98	3.21	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Dr. Lal Pathlabs Ltd.	Q V PT	27,596 Small Cap	1,646.15 (-0.37%)	54.3	11.47	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Aurobindo Pharma Ltd.	Q V+ PT	93,217 Mid Cap	1,620.10 (3.85%)	38.6	4.1	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Laurus Labs Ltd.	Q V+ PT	83,293 Mid Cap	1,541.75 (1.09%)	93.72	15.79	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Novartis India Ltd.	Q V+ PT	3,627 Small Cap	1,469.15 (1.13%)	38.93	4.44	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Cipla Ltd.	Q V PT	1,17,820 Mid Cap	1,458.45 (0.15%)	30.37	3.43	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Jupiter Life Line Hospitals Ltd.	Q V PT	9,539 Small Cap	1,454.85 (0.12%)	49.84	5.93	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Rainbow Childrens Medicare Ltd.	Q V PT	14,620 Small Cap	1,439.45 (1.18%)	58.48	8.66	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Eris Lifesciences Ltd.	Q V PT	19,844 Small Cap	1,432 (-1.05%)	32.03	5.08	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Senores Pharmaceuticals Ltd.	Q V+ PT	6,356 Small Cap	1,380.20 (3.32%)	313.89	8.48	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Dr. Reddys Laboratories Ltd.	Q V PT	1,14,730 Mid Cap	1,374.55 (2.10%)	27.34	3.04	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,043 Small Cap	1,364.80 (-2.44%)	81.19	14.67	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Global Health Ltd.	Q V PT	36,287 Small Cap	1,349.60 (0.30%)	73.13	9.02	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Rubicon Research Ltd.	Q V+ PT	21,545 Small Cap	1,302.75 (-5.22%)	114.5	15.92	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Concord Biotech Ltd.	Q V PT	13,391 Small Cap	1,280.05 (-0.33%)	51.33	6.64	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Sai Life Sciences Ltd.	Q V+ PT	26,663 Small Cap	1,256 (1.44%)	78.08	10.63	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	3B Blackbio Dx Ltd.	Q V PT	1,006 Small Cap	1,172.50 (-2.92%)	20.41	3.69	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Alivus Life Sciences Ltd.	Q V PT	14,200 Small Cap	1,156.95 (-0.22%)	25.16	4.26	9.20	6.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Max Healthcare Institute Ltd.	Q V+ PT	1,12,230 Mid Cap	1,153.15 (2.28%)	77.81	10.44	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Zydus Lifesciences Ltd.	Q V PT	1,13,815 Mid Cap	1,141 (3.76%)	22.58	4.38	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Strides Pharma Science Ltd.	Q V+ PT	10,387 Small Cap	1,126.90 (0.07%)	56.56	3.16	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Supriya Lifescience Ltd.	Q V+ PT	7,884 Small Cap	979.60 (-1.50%)	37.7	6.58	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Fortis Healthcare Ltd.	Q V+ PT	73,586 Mid Cap	974.70 (-0.03%)	319.47	7.97	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Jubilant Pharmova Ltd.	Q V+ PT	15,430 Small Cap	968.75 (-0.40%)	775.39	6.67	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Orchid Pharma Ltd.	Q V PT	4,854 Small Cap	956.95 (-2.10%)	107.36	3.54	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Innova Captab Ltd.	Q V PT	5,474 Small Cap	956.50 (-2.34%)	65.4	6.17	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Natco Pharma Ltd.	Q V PT	16,704 Small Cap	932.60 (-0.13%)	11.78	1.81	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Windlas Biotech Ltd.	Q V PT	1,799 Small Cap	871.70 (1.20%)	27.08	3.5	16.15	15.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	327.55	9.68%
Shree Ganesh Remed.	673.90	4.90%
Piramal Pharma	175.90	4.58%
Dishman Carbogen Amc	196.60	4.57%
Kopran	194.55	4.07%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Rubicon Research	1,302.75	-5.22%
IOL Chem & Pharma	143.05	-4.76%
Bliss GVS Pharma	506.15	-3.87%
Poly Medicure	1,680.05	-3.32%
3B Blackbio Dx	1,172.50	-2.92%

News about Top Pharma Companies in India

Jul, 2026

Fortis Healthcare signs O&M agreement with Dion Group

The O&M agreement is for a 300-bed greenfield multi-specialty hospital to be developed at Dion Riverside Township, Trishulia in Cuttack, Odisha

Jul, 2026

Supriya Lifescience informs about disclosure

Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable laws, and in accordance with the Regulation 30 read with Para B of Part A of Schedule III of the Listing Regulations and SEBI circular dated July 13, 2023 SEBI Listing Regulations, Supriya Lifescience has informed that the investigation has been initiated yesterday against Sreekant Sreedharan, General Manager, Sales & Marketing officer of the Company by Special Investigation and Intelligence branch of Customs Department, subsequent to which judicial custody has been granted by CMM court till July 17, 2026. The Company remains committed to maintaining the highest standards of corporate governance and regulatory compliance. The Company is closely monitoring the developments in the case and any further material developments in the matter shall be disclosed to the stock exchanges in accordance with applicable laws and regulations. The details of the case as required under Circular no SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 are enclosed as Annexure A to the disclosure.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

USFDA completes unannounced inspection at Rubicon Research’s Pithampur facility

Upon conclusion of the inspection, a Form 483 containing 2 observations was issued to the company

Jul, 2026

Senores Pharmaceuticals informs about newspaper publication

Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has enclosed copies of Newspaper Publications as published, in Financial Express -English and Gujarati Edition, on July 03, 2026, regarding completion of dispatch of Notice of Postal Ballot, intimation of e-voting and other related information. This intimation is also being uploaded on the website of the Company i.e. www.senorespharma.com.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Zydus Lifesciences soars on inking pact with Apollo Hospitals to expand access to Shield MCD test in India

The Shield MCD test is a methylation-based blood test for the detection of multiple cancer types

Jul, 2026

Zydus Lifesciences inks pact with Apollo Hospitals to expand access to Shield MCD test in India

The Shield MCD test is a methylation-based blood test for the detection of multiple cancer types

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	54,930 Crore
2	Neuland Laboratories Ltd.	24,270 Crore
3	Apollo Hospitals Enterprise Ltd.	1,27,930 Crore
4	Astrazeneca Pharma India Ltd.	20,745 Crore
5	Divis Laboratories Ltd.	1,79,471 Crore
6	Procter & Gamble Health Ltd.	10,560 Crore
7	Kovai Medical Center & Hospital Ltd.	6,611 Crore
8	Alkem Laboratories Ltd.	66,606 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,432 Crore
10	Torrent Pharmaceuticals Ltd.	1,61,290 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	25.35
Lupin Ltd. (M)	Somewhat Good	2,476	1,13,215	21.23	5.04	12.28	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,542	83,293	103
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	44.17
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	42.84
Aurobindo Pharma Ltd. (M)	Very Good	1,620	93,217	40.20
Gland Pharma Ltd. (S)	Very Good	2,461	40,588	31.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	56.29	9.40	34.09	15.51
Mankind Pharma Ltd. (M)	Very Good	2,531	1,04,535	51.30	6.38	32.20	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,905	4,56,989	39.81	5.47	22.81	23.50
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,210	62,362	45.79	5.93	12.16	14.41

You have 6 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fortis Healthcare signs O&M agreement with Dion Group

Supriya Lifescience informs about disclosure

USFDA completes unannounced inspection at Rubicon Research’s Pithampur facility

Senores Pharmaceuticals informs about newspaper publication

Zydus Lifesciences soars on inking pact with Apollo Hospitals to expand access to Shield MCD test in India

Zydus Lifesciences inks pact with Apollo Hospitals to expand access to Shield MCD test in India

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.